abstract |
The present invention relates to formulated xanthoxyline analogues for use in the treatment of neurodegenerative diseases, to some of said analogues, and also to methods for obtaining same and pharmaceutical compositions that comprise same. The invention also relates to a strain of microorganism of the species |